The comparative cardiovascular and renal effectiveness of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A Scandinavian cohort studyPeter Ueda, Björn Pasternak|Diabetes Obesity and Metabolism|2021Cited by 31
The use of valproic acid and multiple sclerosisNete Munk Nielsen, Anders Hviid, Egon Stenager et al.|Pharmacoepidemiology and Drug Safety|2014Cited by 13